Drug Shortage Report for BLEPHAMIDE OPHT SUSPENSION

Last updated on 2018-04-21
Report ID 40187
Drug Identification Number 00807788
Brand name BLEPHAMIDE OPHT SUSPENSION
Common or Proper name Sulfacetamide sodium
Company Name ALLERGAN INC
Active Ingredient(s) PREDNISOLONE ACETATE SULFACETAMIDE SODIUM
Strength(s) 0.2% 10%
Dosage form(s) DROPS
Route of administration OPHTHALMIC
Packaging size 5mL
ATC code S01CA
ATC description ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB
Reason for shortage Other (Please describe in comments)
Anticipated start date 2018-02-15
Actual start date 2018-02-15
Estimated end date 2018-03-16
Actual end date 2018-04-20
Shortage status Resolved
Updated date 2018-04-20
Company comments Global Production Delay
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5